AU2001225663A1 - A composition comprising a combination of receptor agonists and antagonists - Google Patents

A composition comprising a combination of receptor agonists and antagonists

Info

Publication number: AU2001225663A1
Authority: AU; Australia
Prior art keywords: antagonists; composition; combination; receptor agonists; agonists
Prior art date: 2000-06-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001225663A

Inventor

Staffan Skogvall

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Respiratorius AB

Original Assignee

Respiratorius AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-15

Filing date

2000-12-20

Publication date

2001-12-24

2000-06-15 Priority claimed from PCT/SE2000/001267 external-priority patent/WO2000076500A2/en

2000-12-20 Application filed by Respiratorius AB filed Critical Respiratorius AB

2001-12-24 Publication of AU2001225663A1 publication Critical patent/AU2001225663A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2001225663A 2000-06-15 2000-12-20 A composition comprising a combination of receptor agonists and antagonists Abandoned AU2001225663A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PCT/SE2000/001267 WO2000076500A2 (en)	1999-06-15	2000-06-15	Compound for use as a medicament for treatment of disorders involving bronchocontraction
SESE00		2000-06-15
PCT/SE2000/002612 WO2001095902A1 (en)	2000-06-15	2000-12-20	A composition comprising a combination of receptor agonists and antagonists

Publications (1)

Publication Number	Publication Date
AU2001225663A1 true AU2001225663A1 (en)	2001-12-24

Family

ID=20279203

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2001225663A Abandoned AU2001225663A1 (en)	2000-06-15	2000-12-20	A composition comprising a combination of receptor agonists and antagonists
AU2001225664A Abandoned AU2001225664A1 (en)	2000-06-15	2000-12-20	5-ht3 receptor antagonists for treatment of disorders involving airway constriction

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2001225664A Abandoned AU2001225664A1 (en)	2000-06-15	2000-12-20	5-ht3 receptor antagonists for treatment of disorders involving airway constriction

Country Status (2)

Country	Link
AU (2)	AU2001225663A1 (en)
WO (2)	WO2001095903A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6759029B2 (en)	2001-05-24	2004-07-06	Alexza Molecular Delivery Corporation	Delivery of rizatriptan and zolmitriptan through an inhalation route
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US6737042B2 (en)	2001-05-24	2004-05-18	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US7498019B2 (en)	2001-05-24	2009-03-03	Alexza Pharmaceuticals, Inc.	Delivery of compounds for the treatment of headache through an inhalation route
JP2007516149A (en)	2003-05-21	2007-06-21	アレックザファーマシューティカルズ，インコーポレイテッド	Method for controlling uniformity of substrate temperature, built-in heating unit and chemical supply unit using the same
WO2005089741A2 (en) *	2004-03-17	2005-09-29	Sosei R&D Ltd.	The treatment of inflammatory disorders and pain using beta-aminoalcohols
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en)	2004-08-12	2012-11-21	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heating unit
US7601856B2 (en)	2006-07-27	2009-10-13	Wyeth	Benzofurans as potassium ion channel modulators
ES2594867T3 (en)	2007-03-09	2016-12-23	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
WO2014147636A1 (en) *	2013-03-20	2014-09-25	Suven Life Sciences Limited	5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists
US10058545B2 (en) *	2016-08-09	2018-08-28	Cipla Limited	Method of treating pulmonary arterial hypertension
KR102852740B1 (en)	2018-02-02	2025-08-29	알렉스자 파마스티칼즈, 인크.	Electrical Condensation Aerosol Device
CN115667217A (en)	2020-05-19	2023-01-31	赛本爱尔兰有限公司	Deuterated tryptamine derivatives and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE78162T1 (en) *	1987-11-14	1992-08-15	Beecham Group Plc	5-HT3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF COUGH AND BRONCHOCONSTRICTION.
DK40890D0 (en) *	1990-02-16	1990-02-16	Ferrosan As	SUBSTITUTED URINARY COMPOUNDS, THEIR PREPARATION AND USE
US5399562A (en) *	1994-02-04	1995-03-21	G. D. Searle & Co.	Indolones useful as serotonergic agents
CN1461216A (en) *	1999-04-28	2003-12-10	呼吸器有限公司	Compounds for use as medicaments for the treatment of dysfunctions involving bronchoconstriction
CN1355698A (en) *	1999-06-15	2002-06-26	呼吸器有限公司	Compound for medicine for treating function of bronchial contraction
GB9918425D0 (en) *	1999-08-04	1999-10-06	Novartis Ag	Organic compounds

2000
- 2000-12-20 AU AU2001225663A patent/AU2001225663A1/en not_active Abandoned
- 2000-12-20 AU AU2001225664A patent/AU2001225664A1/en not_active Abandoned
- 2000-12-20 WO PCT/SE2000/002613 patent/WO2001095903A1/en not_active Ceased
- 2000-12-20 WO PCT/SE2000/002612 patent/WO2001095902A1/en not_active Ceased

Also Published As

Publication number	Publication date
AU2001225664A1 (en)	2001-12-24
WO2001095903A1 (en)	2001-12-20
WO2001095902A1 (en)	2001-12-20

Publication	Publication Date	Title
AU2001225663A1 (en)	2001-12-24	A composition comprising a combination of receptor agonists and antagonists
AU2002231098A1 (en)	2002-06-24	Nonpeptide agonists and antagonists of vasopressin receptors
IL150898A0 (en)	2003-02-12	Novel melanocortin receptor agonists and antagonists
AU4552099A (en)	1999-12-30	Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT2 receptors
AU2002366384A1 (en)	2003-09-09	Insulin and igf-1 receptor agonists and antagonists
IL152700A0 (en)	2003-06-24	Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
HUP0100119A3 (en)	2004-04-28	Pharmaceutical compositions comprising estrogen agonists/antagonists suitable for reducing morbidity and the risk of mortality
AU2002222001A1 (en)	2002-06-03	3-arylindole derivatives and their use as CB2 receptor agonists
AU2002213409A1 (en)	2002-05-15	Galphaqproetin variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
IL152701A0 (en)	2003-06-24	Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
AUPP380498A0 (en)	1998-06-25	Egf receptor agonists and antagonists
PL346247A1 (en)	2002-01-28	Muscarinic agonists and antagonists
AU2001290772A1 (en)	2002-03-26	Alpha v integrin receptor antagonists
HUP0300419A3 (en)	2005-07-28	Estrogen agonist/antagonist metabolites, pharmaceutical compositions containing them and their use
AU2002211176A1 (en)	2002-05-15	Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3
AU2002212888A1 (en)	2002-05-15	Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4)
AU2001286409A1 (en)	2002-02-18	N-methyl-d-aspartate receptor antagonists
AU1652601A (en)	2001-05-14	New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist
GB9820014D0 (en)	1998-11-04	Receptor antagonists and uses thereof
AU5861900A (en)	2001-01-02	Receptor agonists and antagonists
AU2002226048A1 (en)	2002-06-24	Urotensin-ii receptor antagonists
AU1100300A (en)	2000-04-26	Piperidyloxadiazoles as dopamine receptor antagonists
AUPQ570100A0 (en)	2000-03-09	Beta-alanine derivatives and their use as receptor antagonists
AU9275001A (en)	2002-04-02	Notch receptor agonists and uses
AU2001249573A1 (en)	2001-10-15	Chemokine receptor antagonists

Legal Events

Date	Code	Title	Description
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
2002-07-25	TH	Corrigenda	Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 25663/01, 58691/01, 63959/01 AND 74155/01